1-117878162-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_017686.4(GDAP2):c.1303-10T>C variant causes a splice polypyrimidine tract, intron change. The variant allele was found at a frequency of 0.00134 in 1,451,832 control chromosomes in the GnomAD database, including 21 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0068 ( 9 hom., cov: 32)
Exomes 𝑓: 0.00070 ( 12 hom. )
Consequence
GDAP2
NM_017686.4 splice_polypyrimidine_tract, intron
NM_017686.4 splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.0008056
2
Clinical Significance
Conservation
PhyloP100: 4.28
Genes affected
GDAP2 (HGNC:18010): (ganglioside induced differentiation associated protein 2) Predicted to act upstream of or within response to retinoic acid. Located in lysosomal membrane. Implicated in autosomal recessive spinocerebellar ataxia 27. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 1-117878162-A-G is Benign according to our data. Variant chr1-117878162-A-G is described in ClinVar as [Benign]. Clinvar id is 3055753.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00679 (1034/152332) while in subpopulation AFR AF= 0.0234 (971/41576). AF 95% confidence interval is 0.0221. There are 9 homozygotes in gnomad4. There are 492 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 9 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GDAP2 | NM_017686.4 | c.1303-10T>C | splice_polypyrimidine_tract_variant, intron_variant | ENST00000369443.10 | NP_060156.1 | |||
GDAP2 | NM_001135589.3 | c.1303-10T>C | splice_polypyrimidine_tract_variant, intron_variant | NP_001129061.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GDAP2 | ENST00000369443.10 | c.1303-10T>C | splice_polypyrimidine_tract_variant, intron_variant | 2 | NM_017686.4 | ENSP00000358451 | P1 | |||
GDAP2 | ENST00000369442.3 | c.1303-10T>C | splice_polypyrimidine_tract_variant, intron_variant | 1 | ENSP00000358450 | |||||
GDAP2 | ENST00000491626.5 | n.309-10T>C | splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00675 AC: 1028AN: 152214Hom.: 9 Cov.: 32
GnomAD3 genomes
AF:
AC:
1028
AN:
152214
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00196 AC: 412AN: 210358Hom.: 1 AF XY: 0.00145 AC XY: 166AN XY: 114442
GnomAD3 exomes
AF:
AC:
412
AN:
210358
Hom.:
AF XY:
AC XY:
166
AN XY:
114442
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000702 AC: 912AN: 1299500Hom.: 12 Cov.: 17 AF XY: 0.000636 AC XY: 412AN XY: 648196
GnomAD4 exome
AF:
AC:
912
AN:
1299500
Hom.:
Cov.:
17
AF XY:
AC XY:
412
AN XY:
648196
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00679 AC: 1034AN: 152332Hom.: 9 Cov.: 32 AF XY: 0.00660 AC XY: 492AN XY: 74494
GnomAD4 genome
AF:
AC:
1034
AN:
152332
Hom.:
Cov.:
32
AF XY:
AC XY:
492
AN XY:
74494
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
GDAP2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 01, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at